BayBio Welcomes New Board Members; BayBio Also Announces New Additions to Its Economic Advisory Board.

SOUTH SAN FRANCISCO, Calif. -- BayBio announced today the election of eight new Directors, bringing its Board of Directors to thirty-seven (37) members. This select group joins BayBio in its effort to serve the life science industry in Northern California.

"These leaders share our commitment to the success of our industry, our philosophy of service and our pledge to contribute to our community," said Matt Gardner, President. "Our region is highly regarded worldwide for its preeminence in life science. Board members of this caliber truly reflect the excellence of Northern California."

In addition, BayBio announced four (4) additions to its Economic Advisory Board, a body of professionals from wide ranging backgrounds gathered to deliver useful information regarding life sciences to our community.

The new members of the BayBio Board of Directors in 2005 include:

    Corey Goodman, Ph.D.
    Renovis, Inc.

    Victoria Hale, Ph.D.
    Institute for OneWorld Health

    Steve James
    KAI Pharmaceuticals

    Joel Marcus
    Alexandria Real Estate Equities, Inc.

    Phil Moody
    Chiron

    Alan Mendelson
    Latham & Watkins LLP

    Kim Popovits
    Genomic Health, Inc.

    Dan Welch
    InterMune

A[micro]   The new members of the BayBio Economic Advisory Board in 2005
include:

    Neil Campbell
    Mosaigen, Inc.

    Tim Garlick
    NASDAQ

    Elliot Parks, Ph.D.
    Ventana Global Funds

    Michael R. Schuppenhauer, Ph.D.
    Fleishman-Hillard Inc.

BayBio is Northern California's life science association. We support the life science community through advocacy, enterprise support, best practice dissemination and enhancement of research collaboration. Our members include organizations engaged in or supportive of research, development, and commercialization of life science technologies. For more information on BayBio, please visit www.baybio.org or call 650-871-7101.